AHCO vs. RDNT, SHC, BTSG, SGRY, WGS, PRVA, CON, LFST, VCYT, and ARDT
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.
AdaptHealth vs.
RadNet (NASDAQ:RDNT) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation, dividends and community ranking.
RadNet presently has a consensus target price of $73.25, indicating a potential upside of 48.22%. AdaptHealth has a consensus target price of $13.80, indicating a potential upside of 29.64%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts plainly believe RadNet is more favorable than AdaptHealth.
RadNet received 267 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.23% of users gave RadNet an outperform vote while only 62.41% of users gave AdaptHealth an outperform vote.
RadNet has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.
In the previous week, RadNet had 14 more articles in the media than AdaptHealth. MarketBeat recorded 18 mentions for RadNet and 4 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.72 beat RadNet's score of 0.81 indicating that AdaptHealth is being referred to more favorably in the news media.
RadNet has a net margin of -0.25% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat RadNet's return on equity.
RadNet has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.
77.9% of RadNet shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 4.4% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
RadNet beats AdaptHealth on 11 of the 19 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 3/28/2025 by MarketBeat.com Staff
